Dr Aaron Wenger reveals how improvements in long-read sequencing technology is enabling the elucidation of complex disease ...

PacBio PACB recently announced a compatibility collaboration with Lucid Genomics, bringing the latter into its Compatible ...

PacBio’s Compatible partner program recognizes third-party providers whose solutions have been evaluated to work seamlessly with PacBio instruments and data formats. As a named partner, Lucid Genomics ...

Former Oxford Pro-Vice-Chancellor for Innovation and former Head of Biology at GSK to lead company’s R&D• Longstanding Scientific Advisory ...

With Helio Liver, patients can have the blood test done right in the office, which is much more convenient. This convenience ...

Researchers from Inocras, a bioinformatics-led company harnessing the power of whole-genome data and proprietary analytics to ...

New algorithms support Illumina TruPath™ Genome: v4.5 introdues analytical support for TruPath, leveraging algorithmic advances to resolve 15 highly homologous, medically-relevant genes for rare ...

ELRIG, a not-for-profit, volunteer-led organization dedicated to the global drug discovery community, today announced the launch of Drug Discovery USA 2026.

Bladder cancer is among the most genomically altered solid tumors, with frequent mutations in epigenetic regulators. Despite progress in characterizing the molecular landscape of this disease, how ...

Neurodevelopmental disorders (NDDs) are characterized by the failure of children to attain expected cognitive, emotional, and motor developmental milestones. These disorders arise from disruptions in ...